Financial Times: The ‘final nail in the coffin’ for AIDS?
“…The question for many — both activists and clinicians — is whether greater use of PrEP alongside more widespread diagnosis and early treatment could finally herald the end of HIV/AIDS. … But PrEP drugs cannot put an end to HIV/AIDS on their own, [NIAID Director Anthony] Fauci warns. They will have to be coupled with other approaches including a vaccine that prevents infection. ‘If deployed alongside our current armory of HIV prevention tools,’ he says, the combination ‘could be the final nail in the coffin for HIV’…” (Greenhalgh/Cookson, 1/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.